---
title: "FREEMAN JONATHAN E — Ownership Dossier"
canonical: https://whiteintel.dev/entity/292e5542-e926-5296-aaaf-91e57a0acdf2
json: https://whiteintel.dev/api/public/dossier/292e5542-e926-5296-aaaf-91e57a0acdf2
identifier: sec:0001708133
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# FREEMAN JONATHAN E

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001708133`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/292e5542-e926-5296-aaaf-91e57a0acdf2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/292e5542-e926-5296-aaaf-91e57a0acdf2  

## Ownership & control

### Holdings / subsidiaries

- **Phio Pharmaceuticals Corp.** (director) — https://whiteintel.dev/entity/e58d0f40-8846-5921-b452-9db6fcc8268b

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **FREEMAN JONATHAN E**. Human view: https://whiteintel.dev/entity/292e5542-e926-5296-aaaf-91e57a0acdf2 · Structured JSON: https://whiteintel.dev/api/public/dossier/292e5542-e926-5296-aaaf-91e57a0acdf2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._